Login or sign up
For business

Syntab Therapeutics

4.2Β· 12 reviews
Average ratingGreat
4.2/ 5

Based on 12 reviews

542%
433%
325%
20%
10%
Ask AI

Ask AI about Syntab Therapeutics

Generated with AI from 12 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website β€” a simple way to convert your visitors into customers.

Get the widget for your site →

About Syntab Therapeutics

Syntab Therapeutics is a German biotech company that has developed an immuno-oncology therapy which employs the innate immune system to kill cancer cells highly effectively and to provide long-lasting anti-cancer benefits to patients. Syntab’s technology platform offers a new path in the cancer therapy space and is expected to exhibit excellent selectivity for a range of cancer-relevant targets. The company established a lean management for its development in tight collaboration with a few selective and excellent academic partners as the group of Prof. Christian Becker in Vienna and Aachen University for preclinical studies. The company has its registered office in WΓΌrselen close to Aachen.